Search results
Why covid patients who could most benefit from paxlovid still aren’t getting it
Texas Tribune via Yahoo News UK· 4 months agoDuring the pandemic, the federal government offered Americans a 5-day course of Paxlovid, the antiviral drug that lessens COVID-19 symptoms. But now that Pfizer is charging for it, confusion over insurance coverage, price, has made patients wary.
Zacks Industry Outlook Highlights CVS Health, Herbalife, Rite Aid and Amazon
Zacks via Yahoo Finance UK· 6 months agoFor Immediate Release Chicago, IL – January 8, 2024 – Today, Zacks Equity Research discusses like...